ERBB family members overexpression has been shown to occur in various treatment resistant cancers including: gefitinib in head and neck squamous carcinoma cells19, gefitinib and erlotinib in lung cancer20, 5-fluorouracil, cytoxan, doxorubicin, taxol, and vinorelbin in breast cancer21. Here, EGFR is linked to cancer.